Delivery Order SPE2DB20D7059-SPE2DB25FQFL4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a ceiling value of $1,217.05. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a contract ceiling value of $4,887.48. This is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,514.00 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Timolol 0.25% Gel-Solution 5ML. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Timolol 0.5% Gel-Solution 5ML, with a ceiling value of $3,427.07. This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,540.02 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor...
- The Defense Logistics Agency awarded a delivery order valued at $1,818.40 to AmerisourceBergen Drug Corp for the supply of Timolol 0.5% Gel-Solution 5mL, a topical ophthalmic medication commonly used to treat glaucoma and ocular hypertension. This firm fixed-price delivery order, issued on August 8, 2025, was competitively awarded with no set-aside designation and carries an ultimate completion date of August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Timolol 0.5% gel-solution. The contract has a ceiling value of $8,822.64 and a period of performance through April 25, 2023. It is a firm-fixed-price contract, with no set-aside requirements. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Timolol 0.5% Gel-Solution, a pharmaceutical product. The contract has a firm fixed price of $2,833.08 and a completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor, and this delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that the company holds with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order contract valued at $31,449.71 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML, a topical ophthalmic medication used in treating glaucoma and ocular hypertension. This firm fixed price delivery order was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Timolol 0.5% Gel-Solution 5ML. The contract has a potential value of $3,080.77 and a period of performance through January 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with a potential value of up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQFL4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Timolol 0.5% Gel-Solution in 5mL units, with a ceiling value of $1,733.29. This is a firm fixed price delivery order with an ultimate completion date of May 2, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 5/1/25 |